Clinical Trial Update: Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a Phase 1/2 clinical trial evaluating CyberKnife SBRT followed by Gemcitabine in patients with unresectable or locally advanced pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Pancreatic Cancer, Unresectable Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED